These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 7483692)

  • 21. [Fibrolamellar hepatocellular cancer].
    Ormann W
    Leber Magen Darm; 1993 May; 23(3):128-31. PubMed ID: 8392127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic Hodgkin's disease simulating cholestatic hepatitis with liver failure.
    Lefkowitch JH; Falkow S; Whitlock RT
    Arch Pathol Lab Med; 1985 May; 109(5):424-6. PubMed ID: 3838655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignant perihilar biliary obstruction: magnetic resonance cholangiopancreatographic findings.
    Yeh TS; Jan YY; Tseng JH; Chiu CT; Chen TC; Hwang TL; Chen MF
    Am J Gastroenterol; 2000 Feb; 95(2):432-40. PubMed ID: 10685746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatocellular carcinoma with tumor thrombi in the bile duct.
    Wang HJ; Kim JH; Kim JH; Kim WH; Kim MW
    Hepatogastroenterology; 1999; 46(28):2495-9. PubMed ID: 10522026
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR imaging of the liver. Primary malignant neoplasms in the adult.
    Buetow PC; Midkiff RB
    Magn Reson Imaging Clin N Am; 1997 May; 5(2):289-318. PubMed ID: 9113676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Chronic increased cholestasis parameters and sonographic echogenic round liver lesions in a clinically healthy male].
    Spengler U; Beuers U; Gokel W; Pape GR; Paumgartner G
    Internist (Berl); 1989 Apr; 30(4):265-8. PubMed ID: 2661467
    [No Abstract]   [Full Text] [Related]  

  • 27. Unusual presentation of a small hepatocellular carcinoma: a case report.
    Lee WC; Chen MF; Jeng LB; Chen TC
    Hepatogastroenterology; 1997; 44(13):153-5. PubMed ID: 9058135
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Fascioliasis--a rare differential diagnosis of liver tumor].
    Maier G; Neugebauer W; el Mouaaouy A; Laudien D; Baumann R
    Chirurg; 1987 Oct; 58(10):686-8. PubMed ID: 3677886
    [No Abstract]   [Full Text] [Related]  

  • 29. Clusterin expression in cholestasis, hepatocellular carcinoma and liver fibrosis.
    Aigelsreiter A; Janig E; Sostaric J; Pichler M; Unterthor D; Halasz J; Lackner C; Zatloukal K; Denk H
    Histopathology; 2009 Apr; 54(5):561-70. PubMed ID: 19413638
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinicopathologic conference. Cholestasis syndrome in epithelioid cell granuloma of the liver: diagnostic and therapeutic difficulties].
    Breuer N; Müller MK; Donhuijsen K; Singer MV; Littmann K; Goebell H
    Med Klin (Munich); 1987 Jan; 82(2):67-71. PubMed ID: 3031440
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical characteristics among patients with hepatocellular carcinoma according to the serum levels of alpha-fetoprotein and des-y-carboxy prothrombin.
    Dohmen K; Shigematsu H; Irie K; Ishibashi H
    Hepatogastroenterology; 2003; 50(54):2072-8. PubMed ID: 14696467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Difficulties in the diagnosis of primary cancer of the liver].
    Chernykh SN; Zeligman VS; Radugina GS; Galalu VV; Monogarova NE
    Klin Med (Mosk); 1989 Oct; 67(10):81-4. PubMed ID: 2559244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Liver cell carcinoma as a late complication of Alagille syndrome (arterio-hepatic dysplasia)].
    Wegmann W; Evison J; Schaub N; Kist L; Vest M
    Leber Magen Darm; 1996 May; 26(3):157-8, 161-3. PubMed ID: 8709830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obstructive jaundice in hepatocellular carcinoma: response after percutaneous transhepatic biliary drainage and prognostic factors.
    Lee JW; Han JK; Kim TK; Choi BI; Park SH; Ko YH; Yoon CJ; Yeon KM
    Cardiovasc Intervent Radiol; 2002; 25(3):176-9. PubMed ID: 12058212
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic features of early hepatocellular carcinoma.
    Yamasaki T; Kurokawa F; Kato A; Irie K; Yutoku K; Terai S; Matsuzaki Y; Yasunaga M; Okita K
    Hepatogastroenterology; 1996; 43(10):926-31. PubMed ID: 8884315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anatomo-pathologic diagnostic interpretation of nodular hepatic lesions].
    Chiaramondia M; Ceppa P; Baccini P; Badini A; Castellaneta A
    Pathologica; 1993; 85(1100):687-99. PubMed ID: 8170717
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein-X in patients with cirrhosis: its relationship to cholestasis and hypercholesterolemia.
    Sörös P; Böttcher J; Maschek H; Selberg O; Müller MJ
    Hepatology; 1998 Nov; 28(5):1199-205. PubMed ID: 9794902
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Alagille's syndrome: a family case and its association with hepatocellular carcinoma].
    Pérez Becerra E; Fuster M; Fraga M; Antúnez J; Pintos E; Pavón P; Forteza J
    Rev Clin Esp; 1991 May; 188(9):459-62. PubMed ID: 1654582
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [On the correlation between histological findings and results of liver function tests: from the pathological standpoint (author's transl)].
    Yamamoto H
    Rinsho Byori; 1979; 27(1):31-4. PubMed ID: 85729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.